Agenda
Programs
Breakout Discussions
Short Courses
Plenary Keynotes
Speaker Biographies
Attendees
1-on-1 Networking
Archives
Sponsor/Exhibitor
Attendee Demographics + Event Features
Sponsorship Opportunities
Current Sponsors
Current Exhibitors/Floorplan
Exhibit Contract
Exhibit Services Schedule
Exhibitor Prospectus
Lead Generation Opportunities
FAQs
Sponsor & Exhibitor Portal
Media
Media Partners
Downloads
Newsroom
Posters
Poster Information
Poster Titles
Register
Event Registration
Group Registration
Press
Warning!
Web API Url is not set for the Speaker Bios.
Speaker Biographies
NAME
ORGANIZATION
PROGRAM
#BostonDOT20
2020 Conference Programs
September 16 - 17
Target Identification and Validation – Part 1
RNA as a Drug Target
PROTACs and Targeted Protein Degradation – Part 1
Lead and Candidate Selection for Therapeutic Proteins
Antibodies Against Membrane Protein Targets – Part 1
Small G Proteins
Immunology and Oncology
Targeting NASH
Disease Modeling
CNS, Gene and Cell Therapy
September 17 - 18
Target Identification and Validation – Part 2
Lead Generation Strategies
PROTACs and Targeted Protein Degradation – Part 2
Modality Selection for Next-Gen Biotherapeutics
Antibodies Against Membrane Protein Targets – Part 2
Kinase Inhibitor Discovery
GPCR-Based Drug Discovery
Targeting Fibrosis
Preclinical Strategies, Models and Tools in Oncology
Clinical and Translational Biomarkers